Site navigation
Our sites
Ten years ago, on 1 March 2016, Australia became the first country to publicly subsidise new direct-acting antiviral (DAA) hepatitis C treatments for the entire population, no matter their condition …
Scientists at Melbourne’s Doherty Institute are asking, “What if there was a way to predict which patients are more likely to achieve functional cure of chronic hepatitis B virus infection?” …
The illness and the damage in lives that will come from abandoning the hepatitis B birth dose vaccine is hard to overstate.
New additions to our Library: The healthy liver pantry, fatty liver disease, hepatitis and mental health, and more...
There are five main hepatitis viruses, helpfully named A, B, C, D and E. The hepatitis D virus (HDV)—sometimes known as hepatitis delta—is relatively little-known because it can only live …
The Federal Government has committed $1.8 million over three years (starting in 2026) to continue the Hepatitis B Partnership Approach to Sustainably Eliminating Chronic Hepatitis B Project in the NT. …
At the start of January, pharmaceutical company GSK announced positive results from its two phase-III trials for bepirovirsen, a potential first-in-class treatment for chronic hepatitis B. They claim that bepirovirsen …
Fighting two infections at once puts an extra-heavy burden on the immune system. In Australia for example, a number of older people with haemophilia live with both hepatitis C and …
Hepatitis Australia, ASHM and the Australian Technical Group on Immunisation (ATAGI) are urging Australians to maintain routine hepatitis B vaccinations for newborns following the alarming news that the advisory panel …
Hepatitis B is Australia’s most prevalent blood-borne virus, with nearly 220,000 people estimated to be living with chronic infection. In a recent report called ‘If Hepatitis was 100 People’, Hepatitis …
Henna is natural dye, orange-red in colour, made from the powdered leaves of Lawsonia inermis and was being used in body art, and as a dye for hair, nails and …
Hepatitis B remains a global public health problem, even in countries like Australia with universal childhood vaccination. For people who have been infected, and who now live with chronic hepatitis B, …
The Australian Government is funding a new hepatitis C awareness campaign to be piloted in Tasmania, as part of national efforts to identify and treat people who may be living with the …
Thousands of Britons have been found to have been living with previously undiagnosed hepatitis and HIV under a new testing system recently introduced in accident and emergency departments by the …
Involvement in a clinical trial may provide access to new treatments and provide participants with a higher level of clinical care, which many people with fatty liver find beneficial.
Part of a liver from a genetically engineered pig has been transplanted into a living human recipient, who then survived a further six months before dying from repeated upper gastrointestinal …
Recent changes to the processing of pathology reports for My Health Record has elevated the importance of pre-test counselling...
A genetic peculiarity that is sometimes found in biochemistry is ‘covalently closed circular DNA‘ (cccDNA), where the DNA molecule, instead of being a long, ribbon-like strand, becomes a closed loop. …
The blood–brain barrier is a hugely effective “wall” that protects the brain from pathogens in a person’s body. It’s like a highly selective, very fine sieve that allows vital nutrients …
As the coronavirus spread globally in 2020, and people all around the world began to be uncomfortably familiar with RAT tests and PCR tests, NSW historian Michelle Bootcov realised her …
The incidence of primary liver cancer in Australia has quadrupled since 1982—faster than any other cancer. Yet, the 5-year survival remains just 22%, in stark contrast to countries like Japan, …
When we at Hepatitis SA talk with members of the community about hepatitis C treatment, we usually point out that the current available cure works for more than 95% of …
A study recently published by a gastroenterology research team in India, has identified a new ”phobia’ in people who have been cured of hepatitis C – the fear of reinfection. …
Two different experimental hepatitis B virus (HBV) treatments have shown very different results in their phase 2 trials in recent weeks. One, while initially promising, has failed to show high …
February 2026
